Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
August 20, 2025Clinical Obesity

Effect of Tirzepatide on the Risk of Developing Type 2 Diabetes Mellitus Among the People Living With Obesity or Overweight: A Systematic Review

View Full Paper
Ask AI
Bookmark
Share

Authors

GPGeeta PardeshiUKUddhav T. KumbharMKMogan Kaviprawin

Discussion

Loading...

Member takes

Overview

Systematic review shows tirzepatide reduces type 2 diabetes risk in people with obesity, implying effective obesity management.

Key Points

  • Tirzepatide significantly lowers the risk of developing type 2 diabetes in people with obesity or overweight, indicating its potential in prevention.
  • The hazard ratio for new-onset diabetes is lower in Tirzepatide patients compared to the Semaglutide group, showing a marked difference in efficacy.
  • A systematic review assessed three studies, including randomized controlled trials, reinforcing the quality of the findings on Tirzepatide.
  • The results indicate that the efficacy of Tirzepatide may provide a promising avenue for diabetes prevention in individuals facing obesity.

Cite This Study

Pardeshi et al. (2025) studied this question.

synapsesocial.com/papers/68af751a7567bf4f94fee2e4https://doi.org/10.1111/cob.70042
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Efficacy and safety of tirzepatide for weight loss in patients with obesity or type 2 diabetes: a systematic review and meta-analysis2025
  2. 2Cardiovascular outcomes of semaglutide and tirzepatide in type 2 diabetes mellitus and obesity: a systematic review and meta-analysis2026
  3. 3Tirzepatide for the treatment of adults living with concurrent type 1 diabetes and overweight or obesity (TZP-T1D): a double-blind, placebo-matched randomised controlled trial protocol2025
  4. 4The Effectiveness of Tirzepatide on Weight Loss in Patients with Type 2 Diabetes Mellitus2025
  5. 5Comparative Efficacy and Tolerability of Tirzepatide Versus Semaglutide at Varying Doses for Weight Loss in Non-diabetic Adults With Obesity: A Network Meta-Analysis of Randomized Controlled Trials2025